Emyria Ltd · ASX:EMD
Mr Greg Hutchinson exercised options for 9,500,000 Emyria Ltd shares (Appendix 3Y, ASX)
Traded Nov 16, 2026 · Filed Nov 18, 2026
On Nov 16, 2026, Mr Greg Hutchinson (Director) exercised options for 9,500,000 Emyria Ltd shares. Filed Nov 18, 2026 (Appendix 3Y, ASX).
- Options exercised
- 9,500,000 shares
- Role
- Director
The filing in full
Appendix 3Y
Change of Director’s Interest Notice
*Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.*
Introduced 30/09/01 Amended 01/01/11
| Name of entity | Emyria Limited |
|---|---|
| ACN | 625 085 734 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director
for the purposes of section 205G of the Corporations Act.
| Name of Director | Mr Greg Hutchinson |
|---|---|
| Date of last notice | 29 May 2026 |
Part 1 - Change of director’s relevant interests in securities
*In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust*
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed
in this part.
| Direct or indirect interest | Indirect |
|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. | Gregory Ross Hutchinson - trustee and beneficiary of the account |
| Date of change | 16 November 2026 |
| No. of securities held prior to change | Gregory Ross Hutchinson - trustee and beneficiary of the account 42,654,762 fully paid ordinary shares. 2,500,000 performance rights (expiring 28 March 2028). 25,580,000 Performance rights (expiring 28 May 2031). 5,000,000 Options exercisable at $0.051 each on or before 28 March 2028. 3,000,000 unlisted Options exercisable at $0.10 each on or before 7 May 2027. 2,527,777 unlisted options exercisable at $0.05 each on or before on 1 March 2027. 10,663,691 unlisted options exercisable at $0.05 each and expiring on 22 March 2027. |
| Class | Fully paid ordinary shares. Performance rights (expiring 28 May 2031). |
| Number acquired | 9,500,000 fully paid ordinary shares |
| Number disposed | 9,500,000 performance rights (expiring 28 May 2031) |
---
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation | Nil – exercise of vested performance rights into fully paid ordinary shares pursuant to the terms and conditions of the Company’s Employee Incentive Plan. |
|---|---|
| No. of securities held after change | Gregory Ross Hutchinson - trustee and beneficiary of the account 52,154,762 fully paid ordinary shares. 2,500,000 performance rights (expiring 28 March 2028). 16,080,000 Performance rights (expiring 28 May 2031). 5,000,000 Options exercisable at $0.051 each on or before 28 March 2028. 3,000,000 unlisted Options exercisable at $0.10 each on or before 7 May 2027. 2,527,777 unlisted options exercisable at $0.05 each on or before on 1 March 2027. 10,663,691 unlisted options exercisable at $0.05 each and expiring on 22 March 2027. |
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back | Exercise of 9,500,000 vested performance rights into 9,500,000 fully paid ordinary shares pursuant to the terms and conditions of the Company’s Employee Incentive Plan. |
Part 2 – Change of director’s interests in contracts – N/A
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed
in this part.
Detail of contract N/A
| Detail of contract | N/A |
|---|---|
| Nature of interest | N/A |
| Name of registered holder (if issued securities) | N/A |
| Date of change | N/A |
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed | N/A |
| Interest acquired | N/A |
| Interest disposed | N/A |
| Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation | N/A |
| Interest after change | N/A |
+ Part 3 – Closed period
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?No
---
| If so, was prior written clearance provided to allow the trade to proceed during this period? | N/A |
|---|---|
| If prior written clearance was provided, on what date was this provided? | N/A |
---
Appendix 3Y
Change of Director’s Interest Notice
*Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.*
Introduced 30/09/01 Amended 01/01/11
| Name of entity | Emyria Limited |
|---|---|
| ACN | 625 085 734 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director
for the purposes of section 205G of the Corporations Act.
| Name of Director | Dr Michael Winlo |
|---|---|
| Date of last notice | 29 May 2026 |
Part 1 - Change of director’s relevant interests in securities
*In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust*
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed
in this part.
| Direct or indirect interest | Direct |
|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. | - |
| Date of change | 16 November 2026 |
---
No. of securities held prior to changeMichael Gordon Winlo* • 1,324,230 fully paid ordinary shares. • 200,000 unlisted options exercisable at $0.10 each on or before 7 May 2027. • 2,000,000 unlisted options exercisable $0.051 each on or before 28 March 2028. • 69,444 unlisted options exercisable at $0.05 each on or before 1 March 2027. • 331,058 unlisted options exercisable at $0.05 each on or before 22 March 2027. • 4,500,000 Performance rights (expiring 28 May 2031).ClassMichael Gordon Winlo - trustee and beneficiary of the account 3,000,000 unlisted Options exercisable at $0.296 each on or before 23 November 2026. *32,148 unlisted options exercisable at $0.12 expired on 5 October 2026.Number acquiredFully paid ordinary shares. Performance rights (expiring 28 May 2031).Number disposed1,000,000 fully paid ordinary sharesValue/Consideration Note: If consideration is non-cash, provide details and estimated valuation1,000,000 performance rights (expiring 28 May 2031)No. of securities held after changeNil – exercise of vested performance rights into fully paid ordinary shares pursuant to the terms and conditions of the Company’s Employee Incentive Plan.Michael Gordon Winlo • 2,324,230 fully paid ordinary shares. • 200,000 unlisted options exercisable at $0.10 each on or before 7 May 2027. • 2,000,000 unlisted options exercisable $0.051 each on or before 28 March 2028. • 69,444 unlisted options exercisable at $0.05 each on or before 1 March 2027. • 331,058 unlisted options exercisable at $0.05 each on or before 22 March 2027. • 3,500,000 Performance rights (expiring 28 May 2031).Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-backMichael Gordon Winlo - trustee and beneficiary of the account 3,000,000 unlisted Options exercisable at $0.296 each on or before 23 November 2026.Exercise of 1,000,000 vested performance rights into 1,000,000 fully paid ordinary shares pursuant to the terms and conditions of the Company’s Employee Incentive Plan.
---
Part 2 – Change of director’s interests in contracts – N/A
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed
in this part.
| Detail of contract | N/A |
|---|---|
| Nature of interest | N/A |
| Name of registered holder (if issued securities) | N/A |
| Date of change | N/A |
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed | N/A |
| Interest acquired | N/A |
| Interest disposed | N/A |
| Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation | N/A |
| Interest after change | N/A |
+ Part 3 – Closed period
| Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? | No |
|---|---|
| If so, was prior written clearance provided to allow the trade to proceed during this period? | N/A |
| If prior written clearance was provided, on what date was this provided? | N/A |
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Fully paid ordinary shares. Performance rights (expiring 28 May 2031). | Option exercise | 9,500,000 |
Source
Download PDF · View original at ASX